Mosaic + Clade C gp140 protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mosaic + Clade C gp140 protein, covering 2025-02-04 to 2025-02-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment [Phase 1]